Trademark Overview
On Monday, April 29, 2024, a trademark application was filed for MYELONEX with the United States Patent and Trademark Office. The USPTO has given the MYELONEX trademark a serial number of 98525965. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 30, 2024. This trademark is owned by Avstera Therapeutics Corp.. The MYELONEX trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:
Cells for scientific and research use; Cells for scientific, laboratory or medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Stem cells for research purposes; Stem cells for scientific and medical research
Research and development in the field of microorganisms and cells; Research in the field of cell engineering technology; Research of induced pluripotent stem cells; Culturing of cells for others for scientific research purposes; Stem cell research services